Skip to main content
Kenneth Carson, MD, Oncology, Chicago, IL

KennethRobertCarsonMD, PhD, FACP

Oncology Chicago, IL

Associate Professor, Hematology/Oncology, Northwestern University Feinberg School of Medicine

Dr. Carson is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Carson's full profile

Already have an account?

  • Office

    675 N Saint Clair St
    Ste 21-100
    Chicago, IL 60611
    Phone+1 312-695-6180
    Fax+1 312-695-1106

Education & Training

  • McGaw Medical Center of Northwestern University
    McGaw Medical Center of Northwestern UniversityFellowship, Hematology and Medical Oncology, 2005 - 2008
  • Duke University Hospital
    Duke University HospitalResidency, Internal Medicine, 2000 - 2003
  • Keck School of Medicine of the University of Southern California
    Keck School of Medicine of the University of Southern CaliforniaClass of 2000

Certifications & Licensure

  • FL State Medical License
    FL State Medical License 2024 - Present
  • IL State Medical License
    IL State Medical License 2004 - 2026
  • MO State Medical License
    MO State Medical License 2008 - 2024
  • NC State Medical License
    NC State Medical License 2003 - 2005
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Hematology
  • American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification Allscripts Enterprise EHR, Allscripts, 2012

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Prevalence of High Tumor Mutational Burden and Association with Survival in Patients with Less Common Solid Tumors  
    Kenneth Carson, MD, JAMA Network Open

Abstracts/Posters

  • Approximating International Myeloma Working Group Uniform Response Criteria to Derive Response for Multiple Myeloma (MM) Patients Using Data from Electronic Health Rec...
    Kenneth R. Carson, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
  • Romidepsin in Combination with Gemcitabine, Oxaliplatin, and Dexamethasone Shows Durable Responses in Aggressive Lymphomas
    Kenneth R. Carson, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
  • Real-World Application of National Comprehensive Cancer Network (NCCN) Testing Guidelines in Diffuse Large B-Cell Lymphoma (DLBCL) Results in Underdiagnosis of Double-...
    Kenneth R. Carson, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
  • Join now to see all

Lectures

  • Hepatitis B Testing Rates in Patients with Chronic Lymphocytic Leukemia before and during Administration of Anti-CD20 Therapy 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
  • Predicting Risk of Venous Thromboembolism in Multiple Myeloma: The Impede VTE Score 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018

Committees

  • Member, 2015 Update Committee, American Society of Clinical Oncology (ASCO) 2015 - Present

Professional Memberships